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Background: In Escherichia coli many heterologous proteins are produced in the periplasm. To direct these
proteins to the periplasm, they are equipped with an N-terminal signal sequence so that they can traverse the
cytoplasmic membrane via the protein-conducting Sec-translocon. For poorly understood reasons, the production
of heterologous secretory proteins is often toxic to the cell thereby limiting yields. To gain insight into the
mechanism(s) that underlie this toxicity we produced two secretory heterologous proteins, super folder green
fluorescent protein and a single-chain variable antibody fragment, in the Lemo21(DE3) strain. In this strain, the
expression intensity of the gene encoding the target protein can be precisely controlled.
Results: Both SFGFP and the single-chain variable antibody fragment were equipped with a DsbA-derived signal
sequence. Producing these proteins following different gene expression levels in Lemo21(DE3) allowed us to
identify the optimal expression level for each target gene. Too high gene expression levels resulted in saturation of
the Sec-translocon capacity as shown by hampered translocation of endogenous secretory proteins and a protein
misfolding/aggregation problem in the cytoplasm. At the optimal gene expression levels, the negative effects of
the production of the heterologous secretory proteins were minimized and yields in the periplasm were optimized.
Conclusions: Saturating the Sec-translocon capacity can be a major bottleneck hampering heterologous protein
production in the periplasm. This bottleneck can be alleviated by harmonizing expression levels of the genes
encoding the heterologous secretory proteins with the Sec-translocon capacity. Mechanistic insight into the
production of proteins in the periplasm is key to optimizing yields in this compartment.
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Escherichia coli is the most widely used bacterial vehicle
to produce heterologous proteins [1]. Proteins are in-
creasingly produced in the periplasm [2-5]. It is easier to
isolate proteins from this compartment than from whole
cell lysates, and, more importantly, in the oxidizing en-
vironment of the periplasm the disulfide bond formation
(Dsb)-system catalyzes the formation of disulfide bonds.
Therefore, disulfide bond containing proteins, like* Correspondence: degier@dbb.su.se
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reproduction in any medium, provided the orantibody fragments and many peptide hormones, are
produced in the periplasm to enable folding into their
native conformation [4,6].
In order to reach the periplasm, the heterologous pro-
teins are equipped with an N-terminal signal sequence
that guides them to the Sec-translocon, which is a
protein-conducting channel in the cytoplasmic mem-
brane [7]. Two pathways can guide proteins to the Sec-
translocon, the post-translational SecB-targeting path-
way and the co-translational signal recognition particle
(SRP)-targeting pathway [8] (Figure 1). The nature of the
signal sequence is decisive for the choice of the targeting
pathway [9-11]. The relatively hydrophobic DsbA signall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The biogenesis of Sec-translocon dependent secretory and cytoplasmic membrane proteins in E. coli. In E. coli, most secretory
and cytoplasmic membrane proteins require the Sec-translocon for their biogenesis. The Sec-translocon is a protein conducting channel in the
cytoplasmic membrane (CM), which mediates the vectorial transfer of secretory proteins across and the biogenesis of membrane proteins in the
cytoplasmic membrane [7]. Secretory proteins are equipped with a cleavable N-terminal signal sequence. The signal sequence determines
whether a secretory protein is targeted to the Sec-translocon via the post-translational SecB-targeting pathway or the co-translational signal
recognition particle (SRP)-targeting pathway, which is comprised of the SRP and its receptor FtsY. Upon translocation, the signal sequence is
cleaved off by leader peptidase (Lep) and the secretory protein is released into the periplasm. In this compartment, the Dsb-system can catalyze
the formation of disulfide bonds. The disulfide oxidoreductase DsbA catalyzes the de-novo formation of disulfide bonds in polypeptide chains.
The disulfide bond formation protein B (DsbB) is essential to maintain DsbA in an oxidized state. Incorrectly formed disulfide bonds can be
corrected by DsbC/D. For a more detailed description of disulfide bond formation in the periplasm of E. coli see [3,5]. Cytoplasmic membrane
proteins are targeted to the Sec-translocon via the SRP-targeting pathway. SecA = peripheral membrane ATPase associated with the
Sec-translocon [18], OM = outer membrane, YidC = cytoplasmic membrane protein translocase/insertase [18].
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an SRP-dependent fashion, is a widely used signal se-
quence for the production of heterologous secretory pro-
teins [12-15]. The Sec-translocon mediates the vectorial
transfer of secretory proteins across the cytoplasmic mem-
brane. Subsequently, the signal sequence is clipped off by
leader peptidase [7,16]. In the periplasm, the Dsb-system
mediates the formation of disulfide bonds and various cat-
alysts guide the folding process [5,17] (Figure 1).
To obtain high yields of a recombinant protein, the gene
encoding this protein is usually expressed at the highest level
possible. Unfortunately, the production of proteins that
carry a signal sequence is, for yet poorly understood reasons,
often toxic to the cell [6]. This negatively affects their yields
in the periplasm. As has been observed for secretory pro-
teins, the production of membrane proteins is also often
toxic to E. coli and, as a consequence, yields are low. In
this bacterium, most cytoplasmic membrane proteins aretargeted to the Sec-translocon in a co-translational fashion
via the SRP-targeting pathway [18] (Figure 1). Recently, we
have shown that the saturation of the Sec-translocon cap-
acity is the main bottleneck in the production and
localization of membrane proteins in the cytoplasmic mem-
brane in E. coli [19-21]. The Lemo21(DE3) strain was critical
to further our understanding of the effect of the saturation
of the Sec-translocon capacity as a major bottleneck in
membrane protein production [20,21]. In this strain, the ex-
pression levels of the gene of interest, i.e., the number of
transcripts synthesized, can be precisely controlled over a
wide range. Adjustment of the expression level of the gene
encoding the membrane protein of interest such that the
Sec-translocon capacity is no longer saturated can minimize
the toxic effects of membrane protein production and pro-
tein levels in the membrane can be optimized [20,21].
Here, we present how cell physiology and periplasmic
protein production are affected by varying gene expression
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fluorescent protein (SFGFP) [22,23] and a single-chain
variable antibody fragment (scFv) in Lemo21(DE3). Both
proteins were equipped with a DsbA-derived signal se-
quence. This approach enabled us to identify the Sec-
translocon capacity as a major bottleneck hampering the
periplasmic production of heterologous proteins. By har-
monizing gene expression levels with the capacity of the
Sec-translocon, protein production in the periplasm can
be optimized.
Results
Modulating gene expression levels using Lemo21(DE3)
To study the effects of varying expression levels of genes
encoding heterologous, secretory proteins on the physi-
ology of the cell and the yields of the proteins in the peri-
plasm, we used two heterologous proteins, SFGFP and the
scFv BL1 [22-25]. SFGFP folds unassisted and its fluores-
cent properties allow rapid detection. The scFv BL1 specif-
ically recognizes E. coli β-galactosidase, providing an easy
diagnostic tool for folding and activity. A DsbA-derived sig-
nal sequence was used to direct these two proteins to the
Sec-translocon. To set varying gene expression levels,
both secretory proteins were produced in Lemo21(DE3)
(Figure 2). Lemo21(DE3) is derived from BL21(DE3) [20].
In BL21(DE3) expression of the target gene is driven
by T7 RNA polymerase (RNAP). Expression of the gene
encoding T7 RNAP is controlled by the isopropyl-β-D-
thiogalactoside (IPTG) inducible lacUV5 promoter, whichFigure 2 Regulating target gene expression levels using the Lemo21(
pLemo plasmid. In Lemo21(DE3), expression of the gene encoding the targ
located on the chromosome. Its expression is governed by the not well-titr
T7 RNAP can be modulated by expression of the gene encoding the natur
plasmid has a p15A ori and a chloramphenicol resistance marker. Expressio
titratable rhamnose promoter. The gene encoding the target protein is loc
used in this study has a kanamycin resistance marker. The expression of th
by the T7lac promoter. The expression levels of the gene encoding the tar
increasing amounts of rhamnose to the culture. The more rhamnose is add
lysozyme on the right). As a consequence, T7 RNAP is increasingly inhibitedis poorly titratable [26]. To create Lemo21(DE3), BL21
(DE3) was transformed with the pLemo plasmid, which
harbors the gene encoding the T7 RNAP inhibitor T7 lyso-
zyme [20]. The expression of this gene is governed by the
well-titratable rhamnose promoter [27] (Figure 2, immuno-
blot right panel inset). When the gene of interest is cloned
in a T7 promoter based expression vector, Lemo21(DE3)
allows screening a wide window of expression levels of the
target gene by adding varying amounts of rhamnose.
Expression levels of the gene encoding secretory SFGFP
affect its accumulation levels in the periplasm
In E. coli, SFGFP is the only known GFP variant that can
fold into its fluorescent form upon translocation via the
Sec-translocon, making it an ideal first target [22,28]. The
gene encoding secretory SFGFP was expressed from a T7
promoter based expression vector in Lemo21(DE3) cul-
tured in the absence and presence of increasing amounts
of rhamnose (Figure 3). Throughout, BL21(DE3) harbor-
ing the expression vector with the gene encoding secretory
SFGFP and Lemo21(DE3) harboring an empty expression
vector were used as references.
Culturing Lemo21(DE3) cells in the presence of in-
creasing amounts of rhamnose resulted in an increase in
biomass formation as determined by A600 measurements
(Figure 3A). SFGFP production was monitored by whole
cell fluorescence measurements (Figure 3B). Whole cell
fluorescence (fluorescence per ml) peaked at a rhamnose
concentration of 50 μM. Fluorescence microscopy revealedDE3) strain. Lemo21(DE3) is a BL21(DE3) derivative harboring the
et protein is driven by T7 RNAP. The gene encoding T7 RNAP is
atable and very strong, IPTG inducible lacUV5 promoter. The activity of
al inhibitor of the T7 RNAP, T7 lysozyme, from pLemo. The pLemo
n of the gene encoding the T7 lysozyme is governed by the well-
ated on a pET-vector. pET-vectors have a ColE1 ori and the version
e gene encoding the target protein from the pET-vector is governed
get protein can be increasingly dampened by the addition of
ed the more T7 lysozyme is synthesized (see immuno-blot of T7
and the expression levels of the target gene decrease (see inset).
Figure 3 Production of secretory SFGFP following varying gene expression levels. Lemo21(DE3) cells harboring a pET-vector with the gene
encoding secretory SFGFP were cultured in LB medium at 30°C. The expression of secretory SFGFP was induced with 400 μM IPTG for 4 h.
Rhamnose was present as indicated. Lemo21(DE3) harboring an empty expression vector (control) and BL21(DE3) producing secretory SFGFP
were included as controls. A The effect of the production of secretory SFGFP following varying gene expression levels on biomass formation was
monitored by measuring the A600. B The effect of the production of secretory SFGFP following varying gene expression levels on protein yields
was monitored as fluorescence per ml of culture. The highest level of fluorescence was set to 100%; the other values were adjusted accordingly.
C The localization of secretory SFGFP in Lemo21(DE3) cells cultured in the absence and presence of increasing concentrations of rhamnose was
monitored directly in whole cells using fluorescence microscopy. Lemo21(DE3) cells producing cytoplasmic SFGFP (i.e., SFGFP not equipped with
a signal sequence) in the absence of rhamnose were included as control.
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halo originated from soluble SFGFP, cells were broken and
separated into a soluble and a non-soluble fraction. The
fluorescent signal originating from the halo was detectable
in the soluble fraction (results not shown). The production
of SFGFP without a signal sequence in Lemo21(DE3), led
to the cytoplasm of the cells being fluorescent (Figure 3C).
This indicates that the secretory SFGFP is directed to the
periplasm. For more detailed information concerning the
localization of SFGFP in E. coli see the comment in the
Additional file 1. Expression of the gene encoding secretory
SFGFP in the BL21(DE3) strain under standard conditions
(see Methods) corresponded to the expression in Lemo21
(DE3) in the absence of rhamnose (Figure 3A, B). Clearly,
BL21(DE3) is far from optimal for the production of
SFGFP in the periplasm.
Consequences of the production of SFGFP following
varying gene expression levels
Our data show that decreasing expression levels of the
gene encoding secretory SFGFP led to a decrease of the
observed negative (toxic) effect on biomass formation(Figure 3). To further our understanding of the observed
effects we used a combination of flow cytometry and
immuno-blotting (Figure 4).
Flow cytometry measurements indicated that both the
cell size (forward scatter) and granularity (side scatter)
decreased with decreasing expression levels of the gene
encoding secretory SFGFP (i.e., increasing rhamnose
concentrations) (Figure 4A). The decrease in cell size
points to a gradual decrease in cell division defects
whereas the decrease in granularity suggests diminished
accumulation of inclusion bodies/aggregates.
To examine potential protein misfolding/aggregation in
the cytoplasm, levels of inclusion body protein B (IbpB)
were monitored using immuno-blotting (Figure 4B). The
expression of the gene encoding IbpB is induced upon
protein misfolding/aggregation in the cytoplasm [29]. At
lower rhamnose concentrations cells contained significant
levels of IbpB. In keeping with the results from the flow
cytometry measurements, levels of IbpB decreased with an
increase in rhamnose concentration. This suggests that
there is a protein accumulation/folding problem in the
cytoplasm if the expression level of the gene encoding a
Figure 4 Consequences of varying expression levels of the gene encoding secretory SFGFP. The expression of the gene encoding
secretory SFGFP was induced with IPTG in Lemo21(DE3) in the absence and presence of increasing concentrations of rhamnose. Lemo21(DE3)
harboring an empty expression vector (control) and BL21(DE3) harboring the secretory SFGFP expression vector were included as controls. 4 h
after induction of the expression of the gene encoding secretory SFGFP cells were analysed by flow cytometry and immuno-blotting. A Cell size
(forward scatter) and granularity (side scatter) were monitored in cells producing secretory SFGFP. B SDS-PAGE/immuno-blotting using antisera
against IbpB, OmpA and MalE. For the immuno-blotting analysis, the precursor (p) and the mature form (m) of OmpA and MalE are indicated.
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ation of the Sec-translocon capacity.
To directly monitor if saturation of the Sec-translocon
capacity indeed plays a role in the observed negative effects
on biomass formation and protein homeostasis in the
cytoplasm, the levels of the endogenous, SecB and Sec-
translocon dependent secretory proteins, OmpA and MalE
were determined using immuno-blotting [30-33] (Figure 4B).
High expression level of the gene encoding secretory SFGFP
in cells grown in the absence or presence of low rhamnose
concentrations led to accumulation of precursor OmpA. For
MalE, an increase in rhamnose concentration led to both a
decrease in precursor MalE and an increase in the mature,
secreted form of the protein. These findings corroborate that
the toxicity observed at high gene expression levels stems
from saturation of the Sec-translocon capacity.
It should be noted that, while visible, the precursor
forms of OmpA and MalE did not accumulate in the
cytoplasm to high levels. This is most likely due to their
partial degradation.
Effects of varying expression levels of the gene encoding
a secretory scFv
To further explore the role of the Sec-translocon cap-
acity in the periplasmic production of heterologousproteins, we used the scFv BL1. Notably, the version
used in this study contains a C-terminal His-tag, facili-
tating its detection and purification.
First, the gene encoding secretory BL1 was expressed
from a T7 promoter based expression vector in Lemo21
(DE3) cultured in the absence and presence of increasing
concentrations of rhamnose. BL21(DE3) harboring the
expression vector with the gene encoding secretory BL1
and Lemo21(DE3) harboring an empty expression vector
were used as references. As for secretory SFGFP, increas-
ing concentrations of rhamnose (i.e., decreasing expres-
sion levels of the gene encoding secretory BL1) resulted
in an increase in cell density (Figure 5A). Immuno-
blotting using an antibody recognizing the C-terminal
His-tag of BL1 showed that increasing amounts of rham-
nose led to increasing amounts of processed, i.e., pre-
sumably periplasmically localized, BL1. Simultaneously,
the non-processed, i.e., cytoplasmically localized, form de-
creased gradually and eventually disappeared (Figure 5B).
Accumulation levels of the processed form of BL1 without
any detectable precursor were highest at a rhamnose con-
centration of 500 μM. This concentration is apparently
optimal for the production of the processed form of
secretory BL1 only. Subcellular fractionation using the
cytoplasmic chaperone GroEL, periplasmic chaperone
Figure 5 Production of the secretory scFv BL1 following varying gene expression levels. Expression of the gene encoding secretory BL1
was induced with IPTG in Lemo21(DE3) cells grown in the absence and presence of increasing concentrations of rhamnose. BL21(DE3) expressing
the gene encoding secretory BL1 and Lemo21(DE3) harboring an empty expression vector were included as controls. A 4 h after induction, cell
growth was monitored by measuring A600. B Levels and processing of secretory BL1 were monitored using SDS-PAGE followed by immuno-
blotting using an α-His antibody. The precursor (p) and the mature (m) form of the protein are indicated. C Using flow cytometry, cell size
(forward scatter) and granularity (side scatter) of cells producing secretory BL1 were monitored. D Levels of IbpB, OmpA and MalE were
monitored using a combination of SDS-PAGE and immuno-blotting. For OmpA and MalE, the precursor (p) and the mature form (m) of the
respective protein are indicated.
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that, as expected, the processed form of BL1 was localized
in the periplasm (Additional file 1: Figure S1) [34]. In
addition, mass spectrometry was used to unambiguously
show that BL1 produced in Lemo21(DE3) cells cultured at
500 μM rhamnose represents the processed form of theprotein, i.e., BL1 lacking the signal sequence (Additional
file 1: Figure S2). It should be noted that the levels of the
precursor form of BL1 at sub-optimal rhamnose concen-
trations are relatively weak. This suggests that not
properly targeted BL1 is partially degraded in the
cytoplasm.
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as observed for secretory SFGFP, cell size and granularity
decreased with increasing rhamnose concentrations
(Figure 5C). The elevated IbpB levels in cells expressing
secretory BL1 at sub-optimal rhamnose concentrations
(Figure 5D) indicated that the observed granularity was
due to the formation of inclusion bodies. In addition,
immuno-blotting revealed the accumulation of precursor
of endogenous secretory proteins (OmpA and MalE)
and reduced levels of the mature form (MalE) at sub-
optimal rhamnose concentrations (Figure 5D). All this
points towards a folding/aggregation problem in the
cytoplasm due to saturation of the Sec-translocon
capacity.
Our observations indicate that the Sec-translocon cap-
acity can be a major bottleneck when producing BL1 in
the periplasm. Modulating the expression levels of the
gene encoding secretory BL1 can be used to alleviate this
bottleneck, thereby optimizing yields of processed BL1.
It should be noted that optimal yields of processed BL1
could only be achieved within a narrow window of gene
expression levels.
Optimization of the expression level of the gene encoding
secretory BL1 leads to functional protein in the periplasm
To address if the optimization of the production of
processed BL1 results in properly folded protein, we ex-
amined the binding ability to its substrate, β-
galactosidase [25]. A whole cell lysate from Lemo21
(DE3) cells producing BL1 at a rhamnose concentra-
tion of 500 μM was prepared. At this rhamnose concen-
tration, only the processed form of BL1 could be
detected (Figure 5B and Additional file 1: Figure S1 and
Figure S2). The substrate of BL1, β-galactosidase, was
spotted in decreasing concentrations on a nitrocellulose
membrane, which was then incubated with the whole
cell lysate. BL1 that bound to β-galactosidase was
detected using an α-His antibody. Bovine serum
albumine (BSA) was used as a negative control. Using
this set-up, we showed that at least part of the BL1 pro-
duced at the optimal rhamnose concentration was cap-
able of binding to its substrate (Figure 6A). Treatment
of whole cell lysate with the reducing agent β-
mercaptoethanol prior to the incubation prevented bind-
ing of BL1 to β-galactosidase (Figure 6A), indicating the
presence of structural disulfide bonds. Mass spectrometry
analysis was used to further explore this observation. To
this end, mature BL1 isolated from whole cells was treated
with iodacetamide only or a reducing agent and
iodactetamide (Additional file 1: Figure S3). Iodacetamide
alkylates free cysteins and consequently the mass of the
protein increases. Treatment with iodacetamide only did
not increase the mass of mature BL1, whereas treatment
with iodacetamide and a reductant led to a clear increasein mass. At the same time, isolated BL1 lost its ability
to bind to β-galactosidase upon reduction/alkylation
(Additional file 1: Figure S4). Taken together, these data
show that disulfide bonds are indeed formed between the
free cysteines of BL1 upon production in the periplasm
and that they are important for the activity of the protein.
As a final step in the characterization of BL1 produced
in the periplasm of Lemo21(DE3) cells cultured at 500
μM rhamnose, the protein was purified from the peri-
plasmic fraction using immobilized metal affinity chro-
matography (IMAC). To assess the homogeneity of this
purified material it was analyzed by means of size exclu-
sion chromatography (SEC) (Figure 6B). The shape of
the SEC trace was symmetric, indicating that the BL1
isolated from the periplasm was homogenous. Finally,
the BL1 present in the fractions representing the sym-
metric peak was pooled and was shown to be active
using the aforementioned β-galactosidase binding assay
(Figure 6B, bottom panel inset).
Taken together, optimizing the expression level of the
gene encoding secretory BL1 results in processed and
properly folded protein in the periplasm.
Discussion
There are two main reasons to produce heterologous
proteins in the periplasm rather than in the cytoplasm
of E. coli. Firstly, the isolation of proteins from the peri-
plasm is usually easier than the isolation of proteins
from total cell lysates, since the periplasm represents a
less complex protein mixture than the cytoplasm [2].
Secondly, the Dsb-system in the periplasm can catalyze
the formation of disulfide bonds, whereas the reducing
cytoplasm prevents disulfide bond formation [4,5]. To
produce heterologous proteins in the periplasm, they are
equipped with an N-terminal signal sequence so that
they can traverse the cytoplasmic membrane via the
Sec-translocon. Unfortunately, the production of heter-
ologous secretory proteins in E. coli often has a severe
negative effect on the formation of biomass and the
yields of processed and properly folded material in the
periplasm are frequently low [6]. To improve periplas-
mic yields of heterologous proteins, it is necessary to
identify the bottlenecks hampering their production.
Here, we have used Lemo21(DE3) to identify what
hampers the production of heterologous secretory pro-
teins in E. coli. Two heterologous secretory proteins,
SFGFP and the scFv BL1, were produced in Lemo21
(DE3) following varying gene expression levels. A deriva-
tive of the E. coli DsbA signal sequence, which funnels
proteins into the co-translational SRP-targeting pathway
and is widely used to produce heterologous secretory
proteins in E. coli, was used to guide the two proteins to
the Sec-translocon. Modulating the expression levels of
the genes encoding the two heterologous secretory
Figure 6 Characterization of secretory BL1 expressed at the optimal rhamnose concentration in Lemo21(DE3). Expression of the gene
encoding secretory BL1 was induced with IPTG in Lemo21(DE3) in the presence of 500 μM of rhamnose (see Figure 5). 4 h after induction a
whole cell lysate was prepared and the periplasmic fraction isolated. A Nitrocellulose membranes containing increasing amounts of β-
galactosidase were incubated with the whole cell lysate (top panel) and whole cell lysate that had been incubated with β-mercaptoethanol
(middle panel). Binding of BL1 to the β-galactosidase spotted on the nitrocellulose membranes was detected using an α-His antibody
recognizing the C-terminal His-tag of BL1. A nitrocellulose membrane containing spots with increasing amounts of BSA and incubated with the
same lysate used in the top panel was included as a control (bottom panel). B The periplasmic fraction was isolated as described in Methods.
SEC was used to analyze the BL1 that was isolated from the periplasmic fraction by means of IMAC. Indicated fractions (inset) from the SEC were
analyzed by SDS-PAGE followed by Coomassie staining (top panel inset) or immuno-blotting using an α-His antibody (middle panel inset). The
fractions representing the indicated peak were pooled and the BL1 was tested for binding to β-galactosidase (bottom panel inset). β-
galactosidase concentrations correspond to the setup described in A. The bottom panel of the inset shows only the first 4 concentrations.
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cells producing SFGFP and BL1, but also on the levels of
SFGFP and BL1 in the periplasm. Notably, our data
show that only a narrow window of expression levels of
the genes encoding the targets results in optimal protein
yields in the periplasm. Sub-optimal conditions, i.e., too
high gene expression levels, led to impaired growth and
low protein yields and too low gene expression levels led
to very low periplasmic protein yields. The protein
misfolding/aggregation problem in the cytoplasm at high
gene expression levels indicates that heterologous
secretory proteins accumulate in the cytoplasm as a re-
sult of saturating the Sec-translocon capacity. This was
corroborated by the impaired translocation of the en-
dogenous secretory proteins OmpA and MalE. The cyto-
plasmic accumulation of endogenous secretory proteins,whose signal sequences are aggregation-prone, and
membrane proteins will lead to the misfolding/aggrega-
tion of proteins in the cytoplasm [19]. Both OmpA and
MalE are targeted to the Sec-translocon in a SecB-
dependent rather than in an SRP-dependent fashion
[33]. This indicates that saturation of the SRP-targeting
pathway is not a bottleneck. Notably, the consequences
of the production of membrane proteins in E. coli at too
high gene expression levels resemble exactly the conse-
quences of the production of SFGFP and the scFv BL1
equipped with a DsbA-derived signal sequence at too
high gene expression levels [20,21]. This strongly sup-
ports the notion that saturation of the Sec-translocon
capacity is the main bottleneck hampering the produc-
tion of the two model secretory proteins used in this
study when the gene expression levels are too high.
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esting observations as to the production of secretory
proteins in E. coli were made that have been waiting for
an explanation ever since. It was shown that levels of
periplasmic PhoA in E. coli could be markedly enhanced
when phoA transcript levels were reduced [35]. In a sub-
sequent study it was shown that the ability of cells to se-
crete proteins into the periplasm was impaired upon
overexpression of phoA [36]. Furthermore, it was shown
that the production of secretory proteins in the peri-
plasm of E. coli could be improved by random alteration
of the translational initiation region of a signal sequence
of a secretory protein [37]. This resulted in varied trans-
lational strengths, which had a great impact on protein
yields in the periplasm. Our work suggests that these ob-
servations can likely be explained by the relief of the sat-
uration of the Sec-translocon capacity upon moderation
of the target protein production levels.
We show in this study that the Sec-translocon capacity
can be a major bottleneck hampering the production of
proteins in the periplasm. It should be kept in mind
though that there may be additional bottlenecks. For
some proteins the co-expression of genes encoding peri-
plasmic chaperones and components of the Dsb-system
can improve their levels in the periplasm [6]. This indi-
cates that chaperone capacity in the periplasm can also
be limiting for the production of proteins in this com-
partment. However, it is also possible that co-expression
of genes encoding periplasmic factors assisting protein
folding helps in clearing the Sec-translocon, thereby in-
creasing Sec-translocon capacity [38].
Conclusions
The Sec-translocon capacity can be a major bottleneck
hampering the production of proteins in the periplasm
of E. coli. Harmonizing the expression levels of the gene
encoding the heterologous secretory protein with the
Sec-translocon capacity alleviates this bottleneck. Opti-
mal yields can only be achieved within a narrow window
of gene expression levels. Importantly, our study shows
that mechanistic insight into the production of proteins




To modulate the expression levels of the genes encoding
secretory SFGFP [23] and BL1 [24,25] in E. coli, the
Lemo21(DE3) strain was used. Lemo21(DE3) is a BL21
(DE3) derivative, harboring a pACYC-derived vector
containing the gene encoding the T7 lysozyme under the
control of the rhamnose promoter (Figure 2). Notably,
the T7 lysozyme K128Y variant that has no amidase ac-
tivity but retains full inhibition of T7 RNA polymerasewas used [39]. The BL21(DE3) strain was used as a refer-
ence. The proteins used in that study were expressed from
a pET28a+ derived vector as described before [21]. The se-
quence encoding SFGFP was obtained from E.L. Snapp
and the gene was synthesized by GeneArt [22]. The genes
encoding SFGFP and BL1 were fused to the genetic infor-
mation encoding a DsbA derived signal sequence (atg tta
aga tcc atg aaa aag att tgg ctg gcg ctg gct ggt tta gtt tta gcg
ttt agc gca tcg gcg) at the 50 end. BL1 is equipped with a
C-terminal His-tag. For cytoplasmic expression of SFGFP,
the gene encoding only SFGFP was used. Lemo21(DE3)
transformed with a pET28a+ derived, “empty” expression
vector served as a negative control.
Culture media and expression conditions
Cells were grown aerobically at 30°C and 200 rpm, in Ly-
sogeny broth (LB) medium (Difco) supplemented with 50
μg/ml kanamycin and 30 μg/ml chloramphenicol (Lemo21
(DE3) only). Lemo21(DE3) was grown in the absence and
presence of increasing concentrations of rhamnose as in-
dicated. At an A600 of ~0.4 protein expression was in-
duced by adding 400 μM IPTG for 4 h. Growth was
monitored by measuring the A600 with an UV-1601 spec-
trophotometer (Shimadzu). Standard deviations shown in
figures of culturing experiments are based on at least three
biologically independent experiments.
Whole cell fluorescence measurements and flow cytometry
Expression of secretory SFGFP was monitored using
whole-cell fluorescence essentially as described before
[40]. Due to the intense fluorescence of cells expressing
SFGFP a volume of 100 μl was used for the whole-cell
fluorescence measurements. For displaying purposes, the
highest expression levels per volume (fluorescence unit/
ml) was set to 100%. Standard deviations are based on a
minimum of three biologically independent experiments.
Cell size and granularity were analyzed by flow cytome-
try using a FACSCalibur instrument (BD Biosciences)
essentially as described before [20,33,41,42]. FM4-64
membrane staining was used to discriminate between cells
and background signal. The FlowJo software (Treestar)
was used for raw data analysis/processing.
SDS-PAGE and immuno-blotting
Whole cell lysates (0.05 A600 units) were analyzed by
standard SDS-PAGE using standard polyacrylamide gels
followed by immuno-blotting as described before [20].
Secretory BL1 was detected using an HRP-conjugated α-
His antibody (ThermoFisher) recognizing the C-terminal
His-tag. T7 lysozyme, IbpB, OmpA and MalE levels were
monitored using respective antisera from our sera col-
lection, followed by incubation with a secondary HRP-
conjugatedgoat-α-rabbit antibody (Bio-Rad). Proteins
were visualized using the ECL-system (GE Healthcare)
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Fuji LAS-1000 charge coupled device (CCD) camera.
Fluorescence microscopy
Prior to microscopy, cells were fixed using cross-linking
reagents. Cells corresponding to 1 A600 unit were har-
vested (4000 × g, 2 min) and resuspended in 1 ml phos-
phate buffered saline (PBS) pH 7.4. Subsequently, 1 ml fix-
ing solution (5.6% Formaldehyde, 0.08% Glutaraldehyde
in PBS) was added and cells were incubated for 15 min at
room temperature (RT). Subsequently, cells were washed
three times with PBS and resuspended in 100 μl PBS. 1 μl
of the cell suspension was mounted on a glass slide. Fluor-
escence images of cells expressing secretory SFGFP were
obtained using a light scanning microscope (LSM 700)
set-up (Zeiss). The resulting images were processed with
the AxioVision 4.5 software (Zeiss).
Preparation of whole cell lysate and BL1 activity assay
The proper folding of BL1 was assayed by the recognition
of its substrate, E. coli β-galactosidase, using a dot-blot
assay and whole cell lysate. Whole cell lysate was obtained
as follows: 35 ml of a Lemo21(DE3) culture expressing
secretory BL1 in the presence of 500 μM rhamnose were
harvested by centrifugation (8000 × g, 20 min, 4°C) and
subsequently resuspended in 1x PBS supplemented with
0.5 mg/ml PefablocSC, 25 μg/ml DNase and 0.05 mg/ml
lysozyme to a final concentration of 10 A600 units/ml. Cell
lysis was performed by passing the cells five times through
an Emulsiflex-C3 (Avestin), at 10.000-15.000 psi. The
lysate was cleared of unbroken cells by centrifugation
(8000 × g, 20 min, 4°C).
For the activity assay, 2 μl of a serial dilution of β-
galactosidase (5 mg/ml, 2.5 mg/ml, 1.25 mg/ml, 0.625
mg/ml, 0.31 mg/ml, 0.15 mg/ml) were spotted directly
onto a nitrocelullose membrane (Millipore) using a BIO-
DOT device (Bio-Rad). As a negative control, the same
amounts of BSA were spotted on a separate membrane.
Non-specific binding sites were blocked by incubating the
membrane with a solution of tris buffered saline
containing 0.05% Tween 20 (TBS-T) with 5% milk for 1 h
at RT. Membranes were washed for three times 15 min
with TBS-T and subsequently incubated for 1 h at RT with
the whole cell lysate. As a negative control, membranes
containing β-galactosidase were treated with 5-6 ml cell
lysates incubated with β-mercaptoethanol (140 μl/A600
unit). Binding of BL1 was visualized using an HRP-
conjugated α-His antibody (Pierce), the ECL-system
(GE Healthcare) and a Fuji LAS-1000 CCD camera.
Isolation of periplasmic fraction and purification of BL1
Cells from 4x 1 l cultures were harvested by centrifuga-
tion (8000 × g, 30 min, 4°C) and the cell pellet was
snap-frozen in liquid nitrogen. All subsequent steps werecarried out on ice or at 4°C. The pellet was resuspended
under gentle agitation in 1 ml ice-cold periplasmic isola-
tion buffer (500 mM sucrose, 100 mM Tris, 1 mM
EDTA, pH 8) per 120 A600 units of cells, supplemented
with 0.5 mg/ml PefablocSC. Spheroplast formation and
release of the periplasmic fraction were facilitated by six
cycles of 5 min incubation at 4°C followed by 10 sec of
vortexing. Spheroplasts were removed by centrifugation
(10.000 × g, 30 min) and the supernatant used for purifi-
cation of BL1.
BL1 was isolated from the supernatant after the isola-
tion of the periplasmic fraction using a combination of
IMAC and SEC. Imidazole and MgCl2 concentrations of
the supernatant were adjusted to 10 mM and 2 mM, re-
spectively. 0.5 ml of Ni-beads (Qiagen) were added to 50
ml of the supernatant and the mixture was incubated at
4°C for 1 h on a rocking table. Ni-beads were concen-
trated (3000 × g, 10 min, 4°C) and loaded onto a gravity
column. The column was washed with 5 column vol-
umes of washing buffer (50 mM NaH2PO4, 300 mM
NaCl, 20 mM imidazole pH 8). BL1 was eluted with 2,8
ml elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250
mM imidazole pH 8) and six fractions were collected.
Fractions containing BL1 (determined by immunoblot-
ting using an α-His antibody) were pooled and diluted in
8 ml gel filtration buffer (150 mM NaCl dissolved in 1 ×
PBS, pH 7.4) The sample volume was reduced to 0.5 ml
by using a vivaspin 20 concentrator (Satoriusstedim) and
the sample was loaded onto a 24 ml Superdex 200 10/
300 GL column (GE Healthcare Bio-Sciences, Uppsala,
Sweden) using an ÄKTA Prime Plus purification system
(GE Healthcare Bio-Sicence). 0.5 ml fractions of the
flow-through were collected at a flow rate of 0.2 ml/min.
The elution profile was monitored by using the Prime
View software (GE Healthcare Bio-Science). Eluted
fractions were analyzed by SDS-PAGE followed by
coomassie staining and immuno-blotting. Fractions
containing no detectable contaminants were pooled and
analyzed with the above described BL1 activity assay
using 2 ml of solution containing BL1 at a final concen-
tration of 17.8 μg/ml.
Additional file
Additional file 1: Figure S1. Subcellular fractionation of BL21(DE3) and
Lemo21(DE3) cells producing secretory BL1. Figure S2. Mass spectrometry
analysis of secretory BL1 produced in Lemo21(DE3). Figure S3. Mass
spectrometry analysis of the redox state of the four cysteines present in
mature BL1. Figure S4. Binding of mature, purified BL1 to β-galactosidase.
Comment The production of secretory SFGFP is discussed in the light of
recent publications.
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